Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M406648200 on August 23, 2004

J. Biol. Chem., Vol. 279, Issue 46, 48024-48037, November 12, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
279/46/48024    most recent
M406648200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McAllister, S. D.
Right arrow Articles by Abood, M. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McAllister, S. D.
Right arrow Articles by Abood, M. E.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Structural Mimicry in Class A G Protein-coupled Receptor Rotamer Toggle Switches

THE IMPORTANCE OF THE F3.36(201)/W6.48(357) INTERACTION IN CANNABINOID CB1 RECEPTOR ACTIVATION*

Sean D. McAllister{ddagger}, Dow P. Hurst§||, Judy Barnett-Norris§||, Diane Lynch§||, Patricia H. Reggio§||, and Mary E. Abood{ddagger}

From the {ddagger}California Pacific Medical Center Research Institute, San Francisco, California 94115 and §Kennesaw State University, Kennesaw, Georgia 30144

In this study, we tested the hypothesis that a CB1 TMH3-4-5-6 aromatic microdomain, which includes F3.25(190), F3.36(201), W5.43(280), and W6.48(357), is centrally involved in CB1 receptor activation, with the F3.36(201)/W6.48(357) interaction key to the maintenance of the CB1-inactive state. We have shown previously that when F3.36(201), W5.43(280), and W6.48(357) are individually mutated to alanine, a significant reduction in ligand binding affinity is observed in the presence of WIN 55,212-2 and SR141716A but not CP55,940 and anandamide. In the work presented here, we report a detailed functional analysis of the F3.36(201)A, F3.25(190)A, W5.43(280)A, and W6.48(357)A mutant receptors in stable cell lines created in HEK cells for agonist-stimulated guanosine 5'-3-O-(thio)triphosphate (GTP{gamma}S) binding and GIRK1/4 channel current effects in Xenopus oocytes where the mutant proteins were expressed transiently. The F3.36(201)A mutation showed statistically significant increases in ligand-independent stimulation of GTP{gamma}S binding versus wild type CB1, although basal levels for the W6.48(357)A mutant were not statistically different from wild type CB1. F3.36(201)A demonstrated a limited activation profile in the presence of multiple agonists. In contrast, enhanced agonist activation was produced by W6.48(357)A. These results suggest that a F3.36(201)/W6.48(357)-specific contact is an important constraint for the CB1-inactive state that may need to break during activation. Modeling studies suggest that the F3.36(201)/W6.48(357) contact can exist in the inactive state of CB1 and be broken in the activated state via a {chi}1 rotamer switch (F3.36(201) trans, W6.48(357) g+) -> (F3.36(201) g+, W6.48(357) trans). The F3.36(201)/W6.48(357) interaction therefore may represent a "toggle switch" for activation of CB1.


Received for publication, June 15, 2004 , and in revised form, August 19, 2004.

* This work has been supported by National Institutes on Drug Abuse Grants DA09978, DA05274 (to M. E. A.), DA00489, and DA03934 (to P. H. R.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

|| Current address: University of North Carolina, Greensboro, NC 27402.

To whom correspondence should be addressed: Forbes Norris ALS/MDA Research Center, 2351 Clay St, Suite 416, California Pacific Medical Center Research Institute, San Francisco, CA 94115. Tel.: 415-600-3607; Fax: 415-563-7325; E-mail: mabood{at}cooper.cpmc.org.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
L. P. Pellissier, J. Sallander, M. Campillo, F. Gaven, E. Queffeulou, M. Pillot, A. Dumuis, S. Claeysen, J. Bockaert, and L. Pardo
Conformational Toggle Switches Implicated in Basal Constitutive and Agonist-Induced Activated States of 5-Hydroxytryptamine-4 Receptors
Mol. Pharmacol., April 1, 2009; 75(4): 982 - 990.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
T. Benned-Jensen and M. M. Rosenkilde
Structural Motifs of Importance for the Constitutive Activity of the Orphan 7TM Receptor EBI2: Analysis of Receptor Activation in the Absence of an Agonist
Mol. Pharmacol., October 1, 2008; 74(4): 1008 - 1021.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
A. Kapur, P. Samaniego, G. A. Thakur, A. Makriyannis, and M. E. Abood
Mapping the Structural Requirements in the CB1 Cannabinoid Receptor Transmembrane Helix II for Signal Transduction
J. Pharmacol. Exp. Ther., April 1, 2008; 325(1): 341 - 348.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Anavi-Goffer, D. Fleischer, D. P. Hurst, D. L. Lynch, J. Barnett-Norris, S. Shi, D. L. Lewis, S. Mukhopadhyay, A. C. Howlett, P. H. Reggio, et al.
Helix 8 Leu in the CB1 Cannabinoid Receptor Contributes to Selective Signal Transduction Mechanisms
J. Biol. Chem., August 24, 2007; 282(34): 25100 - 25113.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
A. Kapur, D. P. Hurst, D. Fleischer, R. Whitnell, G. A. Thakur, A. Makriyannis, P. H. Reggio, and M. E. Abood
Mutation Studies of Ser7.39 and Ser2.60 in the Human CB1 Cannabinoid Receptor: Evidence for a Serine-Induced Bend in CB1 Transmembrane Helix 7
Mol. Pharmacol., June 1, 2007; 71(6): 1512 - 1524.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Fujiwara, D. A. Osborne, M. D. Walker, D.-a. Wang, D. A. Bautista, K. Liliom, J. R. Van Brocklyn, A. L. Parrill, and G. Tigyi
Identification of the Hydrophobic Ligand Binding Pocket of the S1P1 Receptor
J. Biol. Chem., January 26, 2007; 282(4): 2374 - 2385.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
R. P. Picone, A. D. Khanolkar, W. Xu, L. A. Ayotte, G. A. Thakur, D. P. Hurst, M. E. Abood, P. H. Reggio, D. J. Fournier, and A. Makriyannis
(-)-7'-Isothiocyanato-11-hydroxy-1',1'-dimethylheptylhexahydrocannabinol (AM841), a High-Affinity Electrophilic Ligand, Interacts Covalently with a Cysteine in Helix Six and Activates the CB1 Cannabinoid Receptor
Mol. Pharmacol., December 1, 2005; 68(6): 1623 - 1635.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement